WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+12.81%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.5B
Cap. Flow
% of AUM
13.19%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| 1 |
Microsoft
MSFT
|
$247M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$152M |
| 3 |
Brown & Brown
BRO
|
$120M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
$113M |
| 5 |
Akero Therapeutics
AKRO
|
$106M |
Top Sells
| 1 |
Lam Research
LRCX
|
$144M |
| 2 |
MetLife
MET
|
$97.2M |
| 3 |
Travelers Companies
TRV
|
$91.9M |
| 4 |
Electronic Arts
EA
|
$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
$80.3M |
Sector Composition
| 1 | Healthcare | 25.08% |
| 2 | Technology | 24.07% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Agios Pharmaceuticals
AGIO
$2.09B
| $7.75M | 0.04% |
233,068
+212,687
| +1,044% | +$7.07M |
|
477
Immunocore
IMCR
$1.87B
| $7.74M | 0.04% |
246,498
-81,747
| -25% | -$2.57M |
|
478
Arbutus Biopharma
ABUS
$805M
| $7.72M | 0.04% |
2,497,984
-157,754
| -6% | -$487K |
|
479
Amylyx Pharmaceuticals
AMLX
$910M
| $7.69M | 0.04% |
1,200,290
-409,157
| -25% | -$2.62M |
|
480
Carpenter Technology
CRS
$12.3B
| $7.64M | 0.04% |
27,655
+5,304
| +24% | +$1.47M |
|
481
US Bancorp
USB
$75.9B
| $7.63M | 0.04% |
168,530
+36,733
| +28% | +$1.66M |
|
482
Absci
ABSI
$368M
| $7.62M | 0.04% |
2,966,106
+1,574,861
| +113% | +$4.05M |
|
483
Motorola Solutions
MSI
$79.8B
| $7.59M | 0.04% |
18,055
+3,936
| +28% | +$1.65M |
|
484
Analog Devices
ADI
$122B
| $7.51M | 0.04% |
31,553
-129,998
| -80% | -$30.9M |
|
485
Ashland
ASH
$2.51B
| $7.48M | 0.04% |
+148,713
| New | +$7.48M |
|
486
Dianthus Therapeutics
DNTH
$853M
| $7.46M | 0.04% |
400,504
+100,000
| +33% | +$1.86M |
|
487
Travere Therapeutics
TVTX
$1.93B
| $7.41M | 0.04% |
500,995
-728,783
| -59% | -$10.8M |
|
488
Legend Biotech
LEGN
$6.66B
| $7.28M | 0.04% |
205,077
+91,106
| +80% | +$3.23M |
|
489
Edgewell Personal Care
EPC
$1.09B
| $7.28M | 0.04% |
310,799
+225,722
| +265% | +$5.28M |
|
490
CRISPR Therapeutics
CRSP
$4.99B
| $7.26M | 0.04% |
149,267
+12,784
| +9% | +$622K |
|
491
Lantheus
LNTH
$3.72B
| $7.24M | 0.04% |
88,397
| – | – |
|
492
Cogent Biosciences
COGT
$1.82B
| $7.18M | 0.04% |
1,000,611
-686,929
| -41% | -$4.93M |
|
493
Axon Enterprise
AXON
$57.2B
| $7.16M | 0.04% |
8,643
+1,711
| +25% | +$1.42M |
|
494
Vistra
VST
$63.7B
| $7.11M | 0.04% |
36,706
+7,962
| +28% | +$1.54M |
|
495
Bank of New York Mellon
BK
$73.1B
| $7.05M | 0.04% |
77,387
+16,754
| +28% | +$1.53M |
|
496
Intuit
INTU
$188B
| $7.04M | 0.04% |
+8,942
| New | +$7.04M |
|
497
Northern Oil and Gas
NOG
$2.42B
| $7.03M | 0.04% |
247,990
+8,745
| +4% | +$248K |
|
498
EverCommerce
EVCM
$2.06B
| $7.02M | 0.04% |
668,820
+108,314
| +19% | +$1.14M |
|
499
Cytokinetics
CYTK
$6.34B
| $7.01M | 0.04% |
212,303
| – | – |
|
500
Newmont
NEM
$83.7B
| $7.01M | 0.04% |
120,393
+24,211
| +25% | +$1.41M |
|